E
OptiNose, Inc. OPTN
$9.32 -$0.02-0.21% NASDAQ
Recommendation
Prev Close
$9.34
Volume
32,180
Avg Vol (90D)
83,354
Market Cap
$94.59M
Dividend & Yield
--
52-Week Range
$4.82 - $20.03
P/E (TTM)
--
EPS (TTM)
-$2.93
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC ...
4/29/2025 - GuruFocus
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc. - OPTN
4/29/2025 - Business Wire
OptiNose, Inc. (NASDAQ:OPTN) Short Interest Update
4/20/2025 - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, OPTN, AZEK, MESA on Behalf of Shareholders
4/17/2025 - Globe Newswire
OptiNose (OPTN, $9.1) Stochastic Oscillator left the overbought zone on April 14, 2025
4/15/2025 - Tickeron - Stocks
Aster Capital Management DIFC Ltd Reduces Holdings in OptiNose, Inc. (NASDAQ:OPTN)
4/13/2025 - MarketBeat
How a Bucks County firm's multiyear pursuit of a partner led to a potential $330M deal
4/11/2025 - Bizjournals.com - Health Care News
OptiNose (OPTN, $9) Stochastic Oscillator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
OptiNose (OPTN, $9) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 9, 2025
4/10/2025 - Tickeron - Stocks
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders
4/9/2025 - PR Newswire
OptiNose (OPTN, $9.05) price may climb as it broke lower Bollinger Band on Apr 08, 2025
4/9/2025 - Tickeron - Technical Analysis
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, SLRN, AKYA, SHYF on Behalf of Shareholders
4/7/2025 - Globe Newswire
OptiNose (OPTN, $9.1) Stochastic Oscillator left the oversold zone on April 04, 2025
4/5/2025 - Tickeron - Technical Analysis
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - OPTN, SLRN, AKYA, SHYF
4/5/2025 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger OPTN, SLRN, AKYA, SHYF
4/4/2025 - Globe Newswire
OptiNose (OPTN, $9.14) entered Downtrend as Momentum indicator drops below 0 level on Apr 03, 2025
4/4/2025 - Tickeron - Stocks
OptiNose (OPTN, $9.16) Stochastic Oscillator left the overbought zone on April 02, 2025
4/3/2025 - Tickeron - Stocks
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMST, COOP, OPTN, RDFN on Behalf of Shareholders
4/1/2025 - PR Newswire
Bank of New York Mellon Corp Sells 170,507 Shares of OptiNose, Inc. (NASDAQ:OPTN)
3/31/2025 - MarketBeat
OptiNose (NASDAQ:OPTN) Releases Quarterly Earnings Results, Beats Expectations By $0.67 EPS
3/28/2025 - MarketBeat
OptiNose (NASDAQ:OPTN) Releases Earnings Results, Beats Estimates By $0.67 EPS
3/27/2025 - Ticker Report
Biotech Stock Roundup: SAVA Dives on Setback, ALNY Up on Update & More
3/26/2025 - Zacks Investment Research
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates
3/26/2025 - Zacks Investment Research
OptiNose GAAP EPS of -$0.03 beats by $0.76, revenue of $22.42M beats by $1.6M
3/26/2025 - SeekingAlpha.com: All News
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational ...
3/26/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$78.23M
EBITDA (TTM)
-$16.04M
EBIT (TTM)
-$16.32M
Net Income (TTM)
-$21.62M
Balance Sheet
Total Assets (Q)
$128.79M
Total Debt (Q)
$128.96M
Total Liabilities (Q)
$169.15M
Book Value Per Share (Q)
-$4.01
Cash Flow
Cash from Operations (TTM)
-$44.68M
Cash from Investing (TTM)
-$72.00K
Cash from Financing (TTM)
$55.55M
Net Change in Cash (TTM)
$10.80M
Filings
Filing Date
Wednesday, March 26, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
1.30
7-Day Total Return
1.64%
30-Day Total Return
58.50%
60-Day Total Return
57.43%
90-Day Total Return
36.86%
Year to Date Total Return
39.10%
1-Year Total Return
-27.68%
2-Year Total Return
-65.09%
3-Year Total Return
-74.33%
5-Year Total Return
-85.14%
52-week Low
Nov 20, 2024 - $4.82
52-week High
Jun 12, 2024 - $20.03
Valuation
Market Cap
$94.59M - Micro Cap
Enterprise Value
$139.07M
Price/Sales (TTM)
1.39
Price/Book (Q)
-2.33
Dividends and Shares
Shares Outstanding
11.64M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.optinose.com
Phone Number
267 364 3500
Address
777 Township Line Road
Yardley, PA 19067
Country
United States
Year Founded
2000
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. It offers... more
NASDAQ 04/29/2025 4:00PM Eastern Quotes delayed